ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 37 filers reported holding ELEDON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $321,680 | +99800.6% | 234,803 | 0.0% | 0.34% | +8.6% |
| Q2 2023 | $322 | -41.9% | 234,803 | +0.0% | 0.31% | -52.3% |
| Q1 2023 | $554 | +3.6% | 234,800 | 0.0% | 0.66% | +3.0% |
| Q4 2022 | $535 | -99.9% | 234,800 | -4.2% | 0.64% | -15.4% |
| Q3 2022 | $676,000 | +23.1% | 245,000 | +8.9% | 0.76% | +29.3% |
| Q2 2022 | $549,000 | -38.1% | 225,000 | 0.0% | 0.58% | -21.6% |
| Q1 2022 | $887,000 | +75.0% | 225,000 | +95.7% | 0.74% | +94.5% |
| Q4 2021 | $507,000 | +9.3% | 115,000 | +53.3% | 0.38% | +10.7% |
| Q3 2021 | $464,000 | -21.8% | 75,000 | 0.0% | 0.35% | -19.3% |
| Q2 2021 | $593,000 | -26.2% | 75,000 | 0.0% | 0.43% | -28.1% |
| Q1 2021 | $803,000 | – | 75,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $8,280,000 | 0.60% |
| CM Management, LLC | 75,000 | $464,000 | 0.35% |
| BVF INC/IL | 1,363,435 | $8,426,000 | 0.33% |
| Cormorant Asset Management, LP | 1,305,095 | $8,065,000 | 0.33% |
| Ikarian Capital, LLC | 344,578 | $2,129,000 | 0.15% |
| Woodline Partners LP | 781,376 | $4,829,000 | 0.08% |
| Eversept Partners, LP | 114,008 | $704,569 | 0.05% |
| INGALLS & SNYDER LLC | 51,149 | $316,000 | 0.01% |
| Virtu Financial LLC | 18,610 | $115,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 34,630 | $214,000 | 0.01% |